Nick Dearden has been an economic justice campaigner for over 20 years, and his attention was on the pharmaceutical industry when Covid-19 hit. But as the world began to sing the praises of pharmaceutical companies, Nick saw an unprecedented PR coup. Giant corporations capitalised on the crisis, tightening their stranglehold over the health of the […]
Apr 2023
Novara Live: Labour Meet The Tories In The Gutter, BBC Bias On Palestine
In the leadup to the local elections, Labour have joined the Tories in the gutter.
Plus, Mohammed El-Kurd exposes pro-Israel bias on the BBC and a Nike ad campaign sends transphobes into a tailspin.
With Michael Walker and Aaron Bastani.
58m 4s
Apr 2023
Novara Live: 500 Asylum Seekers To Be “Imprisoned” On Barge, More Allegations Against CBI Boss
Aaron and Barnaby Raine discuss why refugees are becoming prisoners, the CBI scandal, a Tory MP media sting, and transphobes attacking Harry Potter’s girlfriend.
59m 22s
Mar 2024
Long Reads: Big Pharma's Toxic Record w/ Nick Dearden
<p>From the HIV/AIDS crisis, to the opioid epidemic, to the COVID-19 pandemic, pharmaceutical corporations have been accused of profiteering at the expense of countless lives. Nick Dearden, director of Global Justice Now and the author of a new book called <a href="https://www.ve ... Show More
53m 19s
May 2024
This Is a Very Weird Moment in the History of Drug Laws
<p>Drug policy feels very unsettled right now. The war on drugs was a failure. But so far, the war on the war on drugs hasn’t entirely been a success, either.</p><p>Take Oregon. In 2020, it became the first state in the nation to decriminalize hard drugs. It was a paradigm shift ... Show More
1h 2m
Dec 2023
Opioid Victims Have a Settlement. Will the Supreme Court Undo It?
<p>The opioid epidemic has been one of the biggest public health disasters in generations. The drug company at the heart of the crisis, Purdue Pharma, maker of the prescription painkiller OxyContin, agreed to a multibillion-dollar deal to settle thousands of claims against it — b ... Show More
23m 50s
Sep 2023
Why One Drug Company Held Back a Better Drug
<p>For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.</p><p>Rebecca Robbi ... Show More
35m 38s